The general trend for metric measures to be adopted in hospitals led to the publication in 1960 of B.S. 3221, Medicine Glasses (Metric Units) for Medicine Glasses of 50 ml. Total Graduated Capacity. The scope of this standard (in future to be known as Part 1) has been extended by issuing Part 2, which deals with glass medicine measures of 30 ml. capacity. The new specification covers materials, design, graduation marking, and tolerances for these measures. In previous articles (Doxiadis et al., 1960 (Doxiadis et al., , 1961 we presented evidence that a great proportion of Greek infants who developed severe neonatal jaundice in the absence of incompatibility or immaturity had an inherited deficiency of the red-cell enzyme glucose-6-phosphate dehydrogenase (G.-6-P.D.) . Such cases had been described also in other communities (Panizon, 1960; Smith and Vella, 1960; Weatherall, 1960; Gilles and Taylor, 1961; Gaburro et al., 1961) . From neither our own nor any other publications was it possible to assess the incidence of severe neonatal jaundice among the newborn infants with this enzyme defect. Also, no attempt has so far been made to find what other factors, apart from the well-known exogenous precipitating agents such as vitamin-K analogues and naphthalene, may contribute to the development of haemolysis and hyperbilirubinaemia in the G.-6-P.D.-deficient neonates.
The present work was undertaken in order to find out (a) the incidence of the G.-6-P.D. deficiency among the newborns of the Alexandra Maternity Hospital, Athens; (b) the incidence of severe neonatal jaundice among the G. -6-P.D.-deficient newborns; and (c) For the assessment of G.-6-P.D. activity of the red cell the Motulsky and Campbell test as described in our previous paper was used (Doxiadis et al., 1961 population of southern Greece and the islands. Although the size of the samples is rather small it is unlikely that any striking difference exists in the incidence of G.-6-P.D. deficiency between the regions represented in our material. Table II shows the incidence of neonatal jaundice among the infants with and without G.-6-P.D. deficiency. The incidence of the different degrees of neonatal jaundice in this group of randomly selected infants was similar to that previously reported (Doxiadis et al., 1961) . The group of infants with G.-6-P.D. deficiency showed an excess of moderate and marked jaundice in comparison to the infants with In Table III the families were divided according to whether the abnormal gene was passed to the infant through the mother or through the father. In four families with male index cases the father was found to be deficient while the mother gave normal results. In these families either the mother was an undetected heterozygote or the mode of transnlission was not sexlinked as is the rule for G.-6-P.D. deficiency.
The incidence of severe jaundice in the siblings of the index cases is much higher than in the unselected population of G.-6-P.D.-deficient male neonates. Thus in the families with maternal transmission, one-third of the male siblings exhibiting G.-6-P.D. deficiency had severe degrees of neonatal jaundice. This ratio increases to one-half if we also take into consideration the siblings who were not tested; six of these had died of kernic- Greece (Zannos-Mariolea and Kattamis, 1961) . Other studies confined to the population of certain small localities have shawn, in some of them, a much higher incidence of this enzyme defect (Choremis et al., 1962; Stamatoyannopoulos and Fessas, personal communication, 1962; Allison and Blumberg, personal communication, 1962) . A higher incidence has also been found in other racial groups (Motulsky and Campbell-Kraut, 1961) .
Our previous experience of the incidence of severe unexplained neonatal jaundice among 22,351 full-term newborn infants, together with the frequency of the abnormal gene, suggested that only a small proportion (by calculation around 5%) of the enzyme-deficient male infants develop severe icterus. In fact, only one of the 21 unselected male newborns with G.-6-P.D. deficiency and no other cause of haemolysis showed any marked hyperbilirubinaemia. The size of this group does not allow an accurate assessment of the magnitude of the risk of severe icterus in the G.-6-P.D.-deficient neonates. Nevertheless this risk is unlikely to be much higher than 5% in the absence of any extrinsic precipitating factor.
The fact that few of the G.-6-P.D.-deficient babies develop severe jaundice made us search for other contributing factors. Known extrinsic factors like vitamin-K analogues and naphthalene were absent in over half of our cases of jaundice developing on the basis of G.-6-P.D. deficiency. For these cases two possibilities can be considered. The first was the operation of some extrinsic and so far unsuspected factor. This possibility can be excluded at least for those of our cases born in the Alexandra Maternity Hospital; the same drugs were given to and the same regimen was followed by the mothers of the G.-6-P.D.-deficient babies whether the babies developed severe jaundice or not.
The second possibility would be the existence of an additional endogenous factor. Such endogenous factor could operate through a variety of mechanisms such as hypoglycaemia, anoxia, immaturity of the liver enzyme systems, and others.
Assuming that such a factor existed, we tried in the present work to find out whether it was genetically determined or not. Such a possibility was suggested by the observation that in many families with G.-6-P.D. deficiency more than one offspring suffered from severe neonatal jaundice.
The family analysis showed that the siblings of our index cases exhibited a much higher incidence of severe neonatal jaundice than might have been anticipated from the incidence of this type of jaundice in the G.-6-P.D.-deficient babies in general. Thus in the families with maternal transmission of the enzyme defect about half of the male G.-6-P.D.-deficient siblings had severe jaundice. The possibility that a common environmental factor was operating in these families seems unlikely because in the siblings born after the index cases in our hospital under strict observation the proportion of jaundiced babies was the same.
The objection might be raised that our figures are biased because families with two affected children are more likely to be sent to us than families with one NEONATAL JAUNDICE Nov. 24, 1962 affected child. If this were true we would expect that the incidence of jaundice in babies born after the index cases would not differ from that observed in the G.-6-P.D.-deficient babies ia general. As our figures show, the incidence was much higher (four out of eight).
Since a common environmental factor operating in these families or bias in the selection of the material can be excluded, we consider that the high incidence of severe neonatal jaundice in certain families with G-6-P.D. deficiency must be also genetically determined. In the present material we have not done any quantitative estimation of enzyme activity, and therefore we cannot exclude the possibility that in these families this activity is particularly low. Assuming that the enzyme level is of importance in the development of haemolysis in the neonatal period and that this level is genetically determined, an accumulation of jaundiced babies in certain families can be explained. The fact that some female heterozygotes displaying almost normal enzyme activity develop severe neonatal jaundice seems to be against a close relationship between enzyme level and haemolysis. However, the recent theory that in heterozygous females the red-cell population can be a mosaic for G.-6-P.D. activity invalidates this objection (Lancet, 1962) .
Another explanation of the accumulation of cases of neonatal jaundice in some families may be the presence of another genetic factor transmitted independently of the G.-6-P.D. deficiency. Since for the development of neonatal hyperbilirubinaemia a multitude of factors may be responsible, this assumed additional genetic factor need not necessarily influence the degree of haemolysis.
An indication for the existence of such an additional genetic factor transmitted independently of the G.-6-P.D. deficiency is our finding that 11 out of 43 male siblings in the families with maternal transmission had severe neonatal jaundice-a ratio of 1 to 4. This is the expected ratio when two independently transmitted factors are needed for the clinical manifestation of a hereditary disorder.
The need of an additional genetic factor for the development of neonatal jaundice may explain the absence of such a clinical manifestation in some racial groups with a high incidence of G.-6-P.D. deficiency. The introduction of a new diuretic (Laragh et al., 1961 Wiebelhaus et at., 1961 Crosley et at., 1962) compound differing from currently available diuretics in its capacity to increase sodium and chloride excretion with little or no increase in potassium output merits further investigation. Furthermore, if it is able alone or in combination with other agents to produce an effective diuresis when other regimes have failed, its place in diuretic therapy demands serious consideration.
The diuretic effect of the administration of triamterene (2,4,7-triamino-6-phenylpteridine; S.K.F. 8542) by mouth to normal individuals and to 10 selected patients with chronic oedema has been studied. In addition, further investigation of the potassium-sparing action of this drug has been made, and its effect on the excretion of uric acid has been studied.
Methods
The nature of the renal action of triamterene was investigated in four normal subjects maintained on a normal diet with constant fluid, sodium, and potassium intake. The subjects continued moderate activity and no drugs other than those on trial were administered. Urine samples were coflected from 8 a.m. to 8 p.m. at two-hourly intervals and a pooled collection was made for the subsequent 12 hours. All the specimens were collected under paraffin and preserved with thymol. After the 24-hour control collection period each individual was given 100 mg. of triamterene by mouth and urine collections were obtained at similar intervals over a further 24 hours.
Clinical trials of triamterene were conducted on 10 selected patients with chronic oedema of varied aetiology. The clinical details are summarized in Table I . Fluid consumption was maintained at 1.5 litres daily and sodium intake was restricted to 25 mEq a day (1.5-g. NaCl diet). All patients were weighed daily, and 24-hour collections of urine were made throughout the period of study. If treatment other than diuretics was
